Nichd: R & D: clinical evaluation of novel products for female contraception pilot and efficacy study: non-severable
Ended Awarded Last action
- Contract number
- HHSN27500003
- Awardee
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$846
Award facts
- Contract value 0% obligated
- $856,215.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 19 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$846 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $68,504 | |
| Supplemental Agreement for work within scope | $218,315 | |
| Other Administrative Action | $0 | |
| Original award | $570,242 |
About this award
The National Institute of Child Health and Human Development awarded The Trustees of the University of Pennsylvania a $856,215.01 cost-no-fee delivery order on September 19, 2014, for clinical evaluation of novel products for female contraception as part of a pilot and efficacy study. This non-severable contract, which was completed on March 31, 2022, supported the Contraceptive Clinical Trials Network Female Sites program and was performed at the university's Philadelphia, Pennsylvania location. No small business set-aside designation was applied to this award, indicating open competition. The University of Pennsylvania's extensive experience as a leading academic medical center and research institution positioned it to conduct the specialized clinical trial activities required under this contract, leveraging its established healthcare delivery infrastructure and clinical research capabilities.
This delivery order was issued under the Contraceptive Clinical Trials Network Female Sites program, which focuses on advancing contraceptive research and development through multi-site clinical trials. The award reflects NICHD's commitment to funding rigorous clinical evaluation of emerging contraceptive technologies to support women's reproductive health options. As a prominent research university with significant federal funding from the National Institutes of Health and other agencies, the University of Pennsylvania has demonstrated sustained capacity to manage complex clinical research protocols and coordinate with multiple institutional partners in support of federal research priorities.
Quick answers
Who was awarded contract HHSN27500003?
HHSN27500003 was awarded to The Trustees Of The University Of Pennsylvania by National Institute of Child Health and Human Development (National Institutes of Health) on September 19, 2014.
How much is contract HHSN27500003 worth?
The government has obligated -$846 on HHSN27500003. Its current value, with exercised options, is $856,215.
Is contract HHSN27500003 an order under another contract?
Yes. HHSN27500003 is a delivery order under HHSN275201300020I, an indefinite delivery contract.
Was contract HHSN27500003 competed?
The extent of competition for HHSN27500003 was full and open competition. The government received 19 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award